NRX Pharmaceuticals, Inc. — Form 8-K
Filed October 16, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 15/100
What the filing says
NRX Pharmaceuticals filed a Form 8-K on October 16, 2026 reporting Item 8.01 (Other Events) and Item 9.01 (Financial Statements and Exhibits). The filing contains only standard XBRL taxonomy extension documents and does not disclose specific material facts, counterparties, dollar amounts, dates, or business developments in the visible text.
Why this rating
No material event disclosed; routine SEC filing containing only metadata and XBRL formatting files with no substantive business content revealed.
Extracted items
- 8.01 other event
- 9.01 exhibits
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.